Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pneumococcal vaccination in Crohn's disease patients
2012-002867-86Phase 4Completed
- Sponsor
- Statens Serum Institut
- Start
- Feb 2013
- Modality
- Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in pneumococcal disease comparing Pneumovax with Prevenar 13 (2 arms). Started Feb 2013; status: completed.
02
Drugs
23-valent pneumococcal polysaccharide vaccinepneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2012-002867-86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002867-86.